NGS Oncology Market Report 2026
Download Free Sample Buy Now
NGS Oncology Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

NGS Oncology Market Report 2026

Global Outlook – By Sequencing Technology (Targeted Sequencing, Genomics, Transcriptomics, Epigenomics), By Offering (Platform, Kits, Services), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Genetic Screening, Hereditary Genetic Testing, Hematological Malignancies, Solid Tumors, Other Applications), By End User (Hospitals And Clinics, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

NGS Oncology Market Overview

• NGS Oncology market size has reached to $19.33 billion in 2025

• Expected to grow to $32.87 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%

• Growth Driver: Increasing Cancer Prevalence Fueling The Growth Of The Market Due To Rising Demand For Precision Diagnostics

• Market Trend: Next-Generation Sequencing Technologies Transforming Oncology Research

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under NGS Oncology Market?

Next-generation sequencing (NGS) oncology refers to the use of advanced sequencing technologies to analyze the genetic makeup of cancer cells. It allows for the identification of specific mutations, genetic alterations, and biomarkers that can help guide personalized treatment plans, predict treatment responses, and improve the overall management of cancer patients. NGS oncology enables precision medicine, where therapies are tailored based on the genetic profile of the tumor.

The main sequencing technologies in NGS oncology include targeted sequencing, genomics, transcriptomics, and epigenomics. Targeted sequencing is a genomic technique that focuses on sequencing specific genes or regions of interest within the genome to identify genetic variations relevant to diseases or traits. These technologies are offered in the form of platforms, kits, and services. The workflow involves stages such as pre-sequencing, sequencing, and data analysis. They are used for various applications, including genetic screening, hereditary genetic testing, hematological malignancies, solid tumors, and others, catering to end users including hospitals and clinics, clinical research organizations (CROs), academic and research institutes, pharmaceutical and biotechnology companies, and others.

NGS Oncology Market Global Report 2026 Market Report bar graph

What Is The NGS Oncology Market Size and Share 2026?

The ngs oncology market size has grown rapidly in recent years. It will grow from $19.33 billion in 2025 to $21.54 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to declining sequencing costs, rising global cancer prevalence, increased oncology research funding, early adoption of targeted therapies, growth of genomic research initiatives.

What Is The NGS Oncology Market Growth Forecast?

The ngs oncology market size is expected to see rapid growth in the next few years. It will grow to $32.87 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expansion of precision oncology programs, growing demand for personalized cancer treatment, increasing approvals of ngs-based diagnostics, advancements in bioinformatics analytics, integration of ngs into clinical guidelines. Major trends in the forecast period include expansion of comprehensive tumor profiling, rising adoption of liquid biopsy NGS, increasing clinical utility of multi-gene panels, integration of NGS in routine oncology diagnostics, growing demand for faster turnaround sequencing workflows.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global NGS Oncology Market Segmentation

1) By Sequencing Technology: Targeted Sequencing, Genomics, Transcriptomics, Epigenomics

2) By Offering: Platform, Kits, Services

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

4) By Application: Genetic Screening, Hereditary Genetic Testing, Hematological Malignancies, Solid Tumors, Other Applications

5) By End User: Hospitals And Clinics, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Targeted Sequencing: Whole Exome Sequencing (WES), Amplicon-Based Sequencing, Hybridization-Based Sequencing

2) By Genomics: Whole Genome Sequencing (WGS), Structural Variant Detection, Copy Number Variation (CNV) Analysis

3) By Transcriptomics: RNA Sequencing, Single-Cell Transcriptomics, Non-Coding RNA Analysis

4) By Epigenomics: DNA Methylation Sequencing, Chromatin Immunoprecipitation Sequencing, Histone Modification Analysis

What Is The Driver Of The NGS Oncology Market?

The rising prevalence of cancer is expected to propel the growth of the NGS oncology market going forward. Cancer is a disease in which abnormal cells grow uncontrollably and can invade other parts of the body, disrupting normal physiological functions. The rise in cancer prevalence is primarily driven by aging populations, population growth, and increasing exposure to risk factors such as tobacco use, alcohol consumption, obesity, and air pollution. NGS oncology supports public health and patient care by enabling early detection, precise diagnosis, and personalized treatment through detailed genetic profiling of tumors. For instance, in January 2024, according to the data published by the American Cancer Society, a US-based non-profit organization, the United States is projected to see 2,001,140 new cancer cases and 611,720 cancer deaths in 2024, compared to 1,958,310 cases and 609,820 deaths in 2023. Therefore, the rising prevalence of cancer is driving the growth of the NGS oncology industry.

Key Players In The Global NGS Oncology Market

Major companies operating in the ngs oncology market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Eurofins Scientific SE, Illumina Inc., Qiagen N.V., Tecan Trading AG, Myriad Genetics, Takara Bio Inc., Beijing Genomics Institute (BGI), Caris Life Sciences, Foundation Medicine, Paradigm Diagnostics, Pacific Bioscience, Horizon Discovery Group plc , Creative-Biolabs, Xcelris Labs Ltd., Partek Inc., 4baseCare, SciGenom Labs Pvt. Ltd.

Global NGS Oncology Market Trends and Insights

Major companies operating in the NGS oncology market are focusing on developing innovative solutions such as liquid biopsy research assays to enable non-invasive, real-time cancer detection and monitoring through the analysis of circulating tumor DNA. A liquid biopsy research assay is a diagnostic test that analyzes biological fluids, such as blood, to detect genetic mutations or other molecular markers associated with cancer, allowing for non-invasive cancer detection and monitoring. For instance, in August 2024, Illumina Inc., a US-based biotechnology company specializing in next-generation sequencing (NGS) technology, expanded its oncology portfolio for NovaSeq X Series users. The company now offers the newly validated high-throughput TruSight Oncology 500 (TSO 500 HT) and the updated TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2) liquid biopsy research assay. These enhanced assays enable laboratories to broaden oncology research capabilities for both tissue and liquid biopsy samples, featuring improved sequencing efficiency, reduced run times, and the ability to process larger sample volumes on the NovaSeq X Series for the first time.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The NGS Oncology Market?

In December 2024, Deerfield Management Company, a US-based investment firm, acquired Singular Genomics for an undisclosed amount. With this acquisition, Deerfield Management Company aims to enhance its portfolio by integrating Singular Genomics' next-generation sequencing and spatial multiomics technologies, advancing research and clinical applications. Singular Genomics is a US-based biotechnology company specializing in next-generation sequencing and multiomics technologies.

Regional Outlook

North America was the largest region in the NGS oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the NGS Oncology Market?

The NGS oncology market consists of revenues earned by entities by providing services such as companion diagnostics, liquid biopsy analysis, genetic mutation analysis, bioinformatics, and data interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The NGS oncology market also includes sales of target enrichment kits, library preparation kits, data analysis pipelines, bioinformatics software, and tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the NGS Oncology Market Report 2026?

The ngs oncology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ngs oncology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

NGS Oncology Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $21.54 billion
Revenue Forecast In 2035 $32.87 billion
Growth Rate CAGR of 11.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Sequencing Technology, Offering, Workflow, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Eurofins Scientific SE, Illumina Inc., Qiagen N.V., Tecan Trading AG, Myriad Genetics, Takara Bio Inc., Beijing Genomics Institute (BGI), Caris Life Sciences, Foundation Medicine, Paradigm Diagnostics, Pacific Bioscience, Horizon Discovery Group plc , Creative-Biolabs, Xcelris Labs Ltd., Partek Inc., 4baseCare, SciGenom Labs Pvt. Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. NGS Oncology Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global NGS Oncology Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. NGS Oncology Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global NGS Oncology Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Expansion Of Comprehensive Tumor Profiling

4.2.2 Rising Adoption Of Liquid Biopsy Ngs

4.2.3 Increasing Clinical Utility Of Multi-Gene Panels

4.2.4 Integration Of Ngs In Routine Oncology Diagnostics

4.2.5 Growing Demand For Faster Turnaround Sequencing Workflows

5. NGS Oncology Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Pharmaceutical And Biotechnology Companies

5.3 Clinical Research Organizations (Cros)

5.4 Academic And Research Institutes

5.5 Diagnostic Laboratories

6. NGS Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global NGS Oncology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global NGS Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global NGS Oncology Market Size, Comparisons And Growth Rate Analysis

7.3. Global NGS Oncology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global NGS Oncology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global NGS Oncology Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. NGS Oncology Market Segmentation

9.1. Global NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted Sequencing, Genomics, Transcriptomics, Epigenomics

9.2. Global NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Platform, Kits, Services

9.3. Global NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pre-Sequencing, Sequencing, Data Analysis

9.4. Global NGS Oncology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Screening, Hereditary Genetic Testing, Hematological Malignancies, Solid Tumors, Other Applications

9.5. Global NGS Oncology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

9.6. Global NGS Oncology Market, Sub-Segmentation Of Targeted Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Exome Sequencing (WES), Amplicon-Based Sequencing, Hybridization-Based Sequencing

9.7. Global NGS Oncology Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Genome Sequencing (WGS), Structural Variant Detection, Copy Number Variation (CNV) Analysis

9.8. Global NGS Oncology Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

RNA Sequencing, Single-Cell Transcriptomics, Non-Coding RNA Analysis

9.9. Global NGS Oncology Market, Sub-Segmentation Of Epigenomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Methylation Sequencing, Chromatin Immunoprecipitation Sequencing, Histone Modification Analysis

10. NGS Oncology Market Regional And Country Analysis

10.1. Global NGS Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global NGS Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific NGS Oncology Market

11.1. Asia-Pacific NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China NGS Oncology Market

12.1. China NGS Oncology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India NGS Oncology Market

13.1. India NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan NGS Oncology Market

14.1. Japan NGS Oncology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia NGS Oncology Market

15.1. Australia NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia NGS Oncology Market

16.1. Indonesia NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea NGS Oncology Market

17.1. South Korea NGS Oncology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan NGS Oncology Market

18.1. Taiwan NGS Oncology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia NGS Oncology Market

19.1. South East Asia NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe NGS Oncology Market

20.1. Western Europe NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK NGS Oncology Market

21.1. UK NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany NGS Oncology Market

22.1. Germany NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France NGS Oncology Market

23.1. France NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy NGS Oncology Market

24.1. Italy NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain NGS Oncology Market

25.1. Spain NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe NGS Oncology Market

26.1. Eastern Europe NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia NGS Oncology Market

27.1. Russia NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America NGS Oncology Market

28.1. North America NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA NGS Oncology Market

29.1. USA NGS Oncology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada NGS Oncology Market

30.1. Canada NGS Oncology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America NGS Oncology Market

31.1. South America NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil NGS Oncology Market

32.1. Brazil NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East NGS Oncology Market

33.1. Middle East NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa NGS Oncology Market

34.1. Africa NGS Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa NGS Oncology Market, Segmentation By Sequencing Technology, Segmentation By Offering, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. NGS Oncology Market Regulatory and Investment Landscape

36. NGS Oncology Market Competitive Landscape And Company Profiles

36.1. NGS Oncology Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. NGS Oncology Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. NGS Oncology Market Company Profiles

36.3.1. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. NGS Oncology Market Other Major And Innovative Companies

Qiagen N.V., Tecan Trading AG, Myriad Genetics, Takara Bio Inc., Beijing Genomics Institute (BGI), Caris Life Sciences, Foundation Medicine, Paradigm Diagnostics, Pacific Bioscience, Horizon Discovery Group plc, Creative-Biolabs, Xcelris Labs Ltd., Partek Inc., 4baseCare, SciGenom Labs Pvt. Ltd.

38. Global NGS Oncology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The NGS Oncology Market

40. NGS Oncology Market High Potential Countries, Segments and Strategies

40.1 NGS Oncology Market In 2030 - Countries Offering Most New Opportunities

40.2 NGS Oncology Market In 2030 - Segments Offering Most New Opportunities

40.3 NGS Oncology Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global NGS Oncology Market, Overview Of Key Products - Product Examples
  • Table 2: Global NGS Oncology Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global NGS Oncology Market, Supply Chain Analysis
  • Table 4: Global NGS Oncology Market, Major Raw Material Providers
  • Table 5: Global NGS Oncology Market, Major Resource Providers
  • Table 6: Global NGS Oncology Market, Major Manufacturers (Suppliers)
  • Table 7: Global NGS Oncology Market, Major Distributors And Channel Partners
  • Table 8: Global NGS Oncology Market, Key Technologies & Future Trends
  • Table 9: Global NGS Oncology Market, Major Trends
  • Table 10: Global NGS Oncology Market, Major End Users
  • Table 11: Global NGS Oncology Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global NGS Oncology Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global NGS Oncology Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global NGS Oncology Market - TAM, US$ Billion, 2025
  • Table 15: Global NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global NGS Oncology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global NGS Oncology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global NGS Oncology Market, Sub-Segmentation Of Targeted Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global NGS Oncology Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global NGS Oncology Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global NGS Oncology Market, Sub-Segmentation Of Epigenomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global NGS Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global NGS Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global NGS Oncology Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global NGS Oncology Market - Company Scoring Matrix
  • Table 100: Hoffmann-La Roche Ltd. Financial Performance
  • Table 101: Thermo Fisher Scientific Inc. Financial Performance
  • Table 102: Agilent Technologies Inc. Financial Performance
  • Table 103: Eurofins Scientific SE Financial Performance
  • Table 104: Illumina Inc. Financial Performance
  • Table 105: Global NGS Oncology Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global NGS Oncology Market, Competitive Dashboard
  • Table 107: Global NGS Oncology Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, NGS Oncology Market Size Gain ($ Billion), Segmentation By Sequencing Technology, 2025 – 2030
  • Table 109: Global, NGS Oncology Market Size Gain ($ Billion), Segmentation By Offering, 2025 – 2030
  • Table 110: Global, NGS Oncology Market Size Gain ($ Billion), Segmentation By Workflow, 2025 – 2030

List Of Figures

    Figure 1: Global NGS Oncology Market, Overview Of Key Products - Product Examples
  • Figure 2: Global NGS Oncology Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global NGS Oncology Market, Supply Chain Analysis
  • Figure 4: Global NGS Oncology Market, Major Raw Material Providers
  • Figure 5: Global NGS Oncology Market, Major Resource Providers
  • Figure 6: Global NGS Oncology Market, Major Manufacturers (Suppliers)
  • Figure 7: Global NGS Oncology Market, Major Distributors And Channel Partners
  • Figure 8: Global NGS Oncology Market, Key Technologies & Future Trends
  • Figure 9: Global NGS Oncology Market, Major Trends
  • Figure 10: Global NGS Oncology Market, Major End Users
  • Figure 11: Global NGS Oncology Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global NGS Oncology Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global NGS Oncology Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global NGS Oncology Market - TAM, US$ Billion, 2025
  • Figure 15: Global NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global NGS Oncology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global NGS Oncology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global NGS Oncology Market, Sub-Segmentation Of Targeted Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global NGS Oncology Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global NGS Oncology Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global NGS Oncology Market, Sub-Segmentation Of Epigenomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global NGS Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global NGS Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global NGS Oncology Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global NGS Oncology Market - Company Scoring Matrix
  • Figure 100: Hoffmann-La Roche Ltd. Financial Performance
  • Figure 101: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 102: Agilent Technologies Inc. Financial Performance
  • Figure 103: Eurofins Scientific SE Financial Performance
  • Figure 104: Illumina Inc. Financial Performance
  • Figure 105: Global NGS Oncology Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global NGS Oncology Market, Competitive Dashboard
  • Figure 107: Global NGS Oncology Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, NGS Oncology Market Size Gain ($ Billion), Segmentation By Sequencing Technology, 2025 – 2030
  • Figure 109: Global, NGS Oncology Market Size Gain ($ Billion), Segmentation By Offering, 2025 – 2030
  • Figure 110: Global, NGS Oncology Market Size Gain ($ Billion), Segmentation By Workflow, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Community Oncology Services Market Report 2026 - Global Outlook – By Type (Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics), By Cancer Type (Breast Cancer, Lung Cance...

Oncology Companion Diagnostics Market Report 2026 - Global Outlook – By Product (Instrument, Consumables, Software), By Disease Type (Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease T...

Oncology Information Systems Market Report 2026 - Global Outlook – By Product (Solutions, Professional Services), By Application (Medical Oncology, Radiation Oncology, Surgical Oncology), By End User (Hospitals And Diagn...

Oncology Devices Market Report 2026 - Global Outlook – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy), By End User (Hosp...

Oncologists Market Report 2026 - Global Outlook – By Cancer Diagnostics And Treatment (Cancer Diagnostics, Cancer Treatment), By Indication (Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, H...

Oncology Nutrition Market Report 2026 - Global Outlook – By Cancer Type (Blood Cancer, Breast Cancer, Stomach And Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Other Cancer Types ), By Nutrition (Enteral Nut...

Frequently Asked Questions

The NGS Oncology market was valued at $19.33 billion in 2025, increased to $21.54 billion in 2026, and is projected to reach $32.87 billion by 2030.

The global NGS Oncology market is expected to grow at a CAGR of 11.2% from 2026 to 2035 to reach $32.87 billion by 2035.

Some Key Players in the NGS Oncology market Include, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Eurofins Scientific SE, Illumina Inc., Qiagen N.V., Tecan Trading AG, Myriad Genetics, Takara Bio Inc., Beijing Genomics Institute (BGI), Caris Life Sciences, Foundation Medicine, Paradigm Diagnostics, Pacific Bioscience, Horizon Discovery Group plc , Creative-Biolabs, Xcelris Labs Ltd., Partek Inc., 4baseCare, SciGenom Labs Pvt. Ltd. .

Major trend in this market includes: Next-Generation Sequencing Technologies Transforming Oncology Research. For further insights on this market. request a sample here

North America was the largest region in the NGS oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us